Legend Biotech Corp (LEGN) Free cash flow 2018–2025
Legend Biotech Corp (LEGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$128.8MFY2025 · since FY2018: $286.7M → -$128.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$128.8M | +18.5% |
| FY2024 | -$158.1M | +61.8% |
| FY2023 | -$413.4M | -86.0% |
| FY2022 | -$222.2M | +7.7% |
| FY2021 | -$240.7M | +3.4% |
| FY2020 | -$249.3M | -126.9% |
| FY2019 | -$109.8M | -138.3% |
| FY2018 | $286.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice